Tomomi Takeuchi and Eric Poliner start new positions at Michigan biotech companies
MSU-DOE Plant Research Laboratory (PRL) couple, Tomomi Takeuchi and Eric Poliner, have each joined a Michigan-based biotech company this past month.
Tomomi is employed by Charles River Labs in Mattawan, MI, in the Biomarkers and Investigative Pathology Unit.
Charles River is a drug manufacturer with 90+ facilities in over 20 countries and over 14,000 employees. The company is a contract research organization that offers a range of services that span the drug discovery and development continuum. The company’s site in Mattwan, MI primarily deals with safety assessments of novel therapeutics.
Tomomi, in her new Scientist position, will tackle developing and validating methods and procedures to test chemical entities or study chemical compounds in vitro or in vivo.
"Michigan State University and the Benning lab have been a great place for me to develop my skills as a scientist, and I hope I can apply them in my new job in the industry to make positive impacts on people's lives,” Tomomi says.
Eric, in turn, is a Laboratory Scientist with Physicians Toxicology in Kalamazoo, MI. The company specializes in delivering custom medication monitoring, personalized service, and education. Eric will be developing test protocols for new quality assurance applications.
“I would like to thank and credit PRL for being a great learning environment for me and giving me a lot of opportunity as I move forward with my career,” Eric says.
Congrats Eric and Tomomi!
Share this story
A new study delves into how algae manage cell division processes when they suffer from starvation. The finding has implications for biofuel technologies, given that algae have the potential to become a sustainable source of high value oils.
Kellie Walters and Bryan Ferlez were both recognized as scientists who exemplify the research excellence, ideas, dedication, and vision of former PRL director, Anton Lang.
MSU Foundation Professor, Beronda Montgomery, will bring her talents to the Office of Research & Innovation as interim assistant vice president. She joined the team in a half-time capacity effective Sept. 15, 2020.